Effect of Omega-3 Fatty Acids on Sleep and Behavior (Pilot Study)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

29 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-05-15

Study Completion Date

2019-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this feasibility study is to determine whether a nutritional intervention in children and their parents can improve their sleep quality and behavior. The study is a randomized, double-blind, placebo-controlled parallel trial of omega-3 supplementation to children and their mothers.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of Omega-3 Fatty Acids Supplementation on Brain and Behaviour in Healthy Children.

NCT02346773

Behaviour

COMPLETED NA

Effect of Omega-3 Supplementation on Child Behavior Problems

NCT02016079

Antisocial Aggressive Externalizing Behavior Problems +1 more

COMPLETED PHASE2/PHASE3

Investigation of Psychophysiological Response to Aversive Stimuli Over Time With Omega-3

NCT03749824

Conduct Disorder ADHD Oppositional Defiant Disorder

COMPLETED NA

Omega-3 Supplementation to Both Parent and Adolescent

NCT05893550

Behavior Problems

UNKNOWN PHASE3

Effect of Omega-3 Supplements on Stress, Anxiety, Depression, Memory and Sleep Quality Among Saudis

NCT07157241

Healthy Adults Anxiety Depression +3 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Previous studies show omega-3 fatty acid supplements improve adolescent's antisocial behavior. However it is less known whether the same effect could be achieved in younger children. Furthermore it is not known whether omega-3 fatty acids could also improve parental behavior and parenting style which could further reduce behavioral problems in children. Moreover, we recently found that children who consume fish more frequently have less sleep problems but it is not known whether omega-3 supplements could also potentially improve children's sleep. We aim to test several hypotheses in this random controlled trial of omega-3 fatty acids.

The study design will consist of a double-blind, randomized placebo-controlled trial of children and their caregivers in a community sample in the city of Philadelphia. It will utilize a random parallel design, in which child and mother pairs will be randomly assigned to either omega-3 supplementation (treatment condition) or a placebo (control condition). This results in 2 groups: (1) child and caregiver both receiving omega-3 and (2) both parent and child receiving the placebo. Treatment will last 45 days. Assessments will take place at 0 months (baseline), 45 days (end of supplementation) and 90 days (45 days after the end of treatment).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Disturbances in Initiating and Maintaining Sleep Behavior Problem

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Omega-3 fatty acids

Both the mother and child will receive omega-3 supplements in the form of a 200 mL drink to be taken once daily. The intervention will last 45 days. Assessments will take place at 0 months (baseline), 45 days (end of treatment), and 3 months (1 and a half months post-treatment).

Group Type EXPERIMENTAL

Omega-3 fatty acids

Intervention Type DIETARY_SUPPLEMENT

200 ml drink. The drink contains 840 mg total of omega-3 (360 mg of DHA, 240 mg of EPA, 200 mg of alpha-linolenic acid, and 40 mg of DPA).

Placebo

The mother and child will both receive a placebo drink to take daily, with no known effect on the brain. The intervention will last 45 days. Assessments will take place at 0 months (baseline), 45 days (end of treatment), and 3 months (1 and a half months post-treatment).

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

200 mL placebo fruit juice with no effect on the hypothesized outcome.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Omega-3 fatty acids

200 ml drink. The drink contains 840 mg total of omega-3 (360 mg of DHA, 240 mg of EPA, 200 mg of alpha-linolenic acid, and 40 mg of DPA).

Intervention Type DIETARY_SUPPLEMENT

Placebo

200 mL placebo fruit juice with no effect on the hypothesized outcome.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* child between ages 5-9 with mother available to participate in intervention study

Exclusion Criteria

* intellectual disability
* significant psychiatric and physical illness
* extensive use of nutritional supplements within the past three months
* seafood allergy
* diabetes

Minimum Eligible Age

5 Years

Maximum Eligible Age

9 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes